Bio Essence BIOE

OTC BIOE
$0.27 +0.00 (+0.00%)
At close: Jul 15, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap13.45 Mn
P/E8.38
P/S4.62
Div. Yield0.00
Revenue Growth (1y) (Qtr)206.69
Add ratio to table…

About

Bio Essence Corp. is an herbal health, diet, and nutrition company that provides herbal health, diet, and vitamin nutritional supplements. The company’s mission is to deliver natural wellness solutions through scientifically supported herbal formulations. It sells its own branded supplement lines and also provides original equipment manufacturing and private label services to other supplement firms. Its product portfolio includes single herb extracts, granule formulations,…

Read more ↓
Sectors: Consumer Staples · Industrials Sector rationale The company's primary revenue is generated from the sale of branded herbal health, diet, and vitamin nutritional supplements to consumers and wholesale channels, which falls under the 'Personal Care Products' or 'Packaged Foods' logic of Consumer Staples. A secondary sector of Industrials is justified because the company operates a substantial business line providing original equipment manufacturing (OEM), private label services, and custom formulation for other supplement firms, which constitutes a business-facing operating service. Industries: Personal Care Products Consumer Staples Primary Bio Essence Corp. manufactures and markets herbal health, diet, and vitamin nutritional supplements, which are explicitly covered under personal-care and consumer-health sales in S-11. The company sells branded supplement lines including single herb extracts, granule formulations, pills, and tablets to individual consumers. Industrial Machinery Industrials Secondary The company provides original equipment manufacturing (OEM) and private label services to other supplement firms, which involves the use of process and packaging machinery to produce goods for business clients. This contract manufacturing activity for other brands constitutes a material business line. Classified using BQ-MICS CIK: 0001723059

Product and Service Breakdown of Revenue (2025)

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 43.91 Bn40.671.67-5.81 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 43.07 Bn61.882.4916.59 Bn
3 ZTS Zoetis Inc. 31.54 Bn9.643.319.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 28.61 Bn12.450.6231.47 Bn
5 UTHR UNITED THERAPEUTICS Corp 22.19 Bn16.937.04-
6 VTRS Viatris Inc 18.68 Bn-45.481.2713.35 Bn
7 NBIX Neurocrine Biosciences Inc 15.50 Bn21.974.59-
8 ELAN Elanco Animal Health Inc 11.76 Bn-59.092.343.92 Bn